Dynamische kontrastverstärkte MRT zur Beurteilung der Knochenmarksmikrozirkulation bei malignen hämatologischen Erkrankungen vor und während einer Thalidomidtherapie View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-03

AUTHORS

A. Scherer, C. Strupp, H.-J. Wittsack, V. Engelbrecht, R. Willers, U. Germing, N. Gattermann, R. Haas, U. Mödder

ABSTRACT

Purpose. The aim of the study was to measure microcirculation parameters by dynamic contrast-enhanced MRI (d-MRI) and to evaluate the anti-angiogentic effects during treatment with thalidomide in different hematologic malignancies.Methods. In 20 healthy normal persons, 20 patients with myelodysplastic syndromes (MDS), 10 patients with multiple myeloma (MM) and 10 with myelofibrosis (MF) a fast gradient echo sequence (Turbo fast low angle shot 2D) with a pump controlled bolus infusion of gadolinium-DTPA was performed before and in 18 of these after beginning (average of 4,3 months) of a thalidomide therapy. Two pharmacokinetic parameters – the amplitude and exchange-rate-constant – were calculated and a statistical comparison of these values between healthy persons and patients as well as a correlation with the clinical course was executed.Results. Compared with the normal controls the patients showed a higher amplitude (normal persons 14.4±5.2, MDS 24.8±8.1, MF 35.9±4.3, MM 23.4±3.6) and exchange-rate-constant (normal persons 0.124±0.042, MDS 0.136±0.036, MF 0.144±0.068, MM 0.131±0.034). In the d-MRI-follow-up examinations a significant (p<0.005) reduction of the amplitude and exchange rate constant values was evident in 14 of 18 patients undergoing a thalidomide therapy. Clinically all of these patients showed a therapy responding with complete or partial diseases remission.Conclusions. In patients with hematologic malignancies significantly higher d-MRI-microcirculation parameters of the lumbar spine can be demonstrated than in normal persons. During anti-angiogenetic treatment with thalidomide a decrease of these values was observed in case of a responding to therapy. More... »

PAGES

222-230

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00117-002-0721-6

DOI

http://dx.doi.org/10.1007/s00117-002-0721-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050758582

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11963240


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiogenesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Contrast Media", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gadolinium DTPA", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Image Enhancement", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Image Processing, Computer-Assisted", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lumbar Vertebrae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microcirculation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Myeloma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelodysplastic Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neovascularization, Pathologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Primary Myelofibrosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thalidomide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scherer", 
        "givenName": "A.", 
        "id": "sg:person.0627026525.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627026525.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr H\u00e4matologie, Onkologie und klinische Immunologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Klinik f\u00fcr H\u00e4matologie, Onkologie und klinische Immunologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strupp", 
        "givenName": "C.", 
        "id": "sg:person.01001653715.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001653715.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wittsack", 
        "givenName": "H.-J.", 
        "id": "sg:person.0675141725.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675141725.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Engelbrecht", 
        "givenName": "V.", 
        "id": "sg:person.01077215375.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077215375.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e4tsrechenzentrum, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Universit\u00e4tsrechenzentrum, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Willers", 
        "givenName": "R.", 
        "id": "sg:person.010643554674.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010643554674.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr H\u00e4matologie, Onkologie und klinische Immunologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Klinik f\u00fcr H\u00e4matologie, Onkologie und klinische Immunologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Germing", 
        "givenName": "U.", 
        "id": "sg:person.01362464041.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr H\u00e4matologie, Onkologie und klinische Immunologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Klinik f\u00fcr H\u00e4matologie, Onkologie und klinische Immunologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gattermann", 
        "givenName": "N.", 
        "id": "sg:person.01273447501.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haas", 
        "givenName": "R.", 
        "id": "sg:person.01127414674.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Institut f\u00fcr Diagnostische Radiologie, Heinrich-Heine Universit\u00e4t D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "M\u00f6dder", 
        "givenName": "U.", 
        "id": "sg:person.0637037231.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637037231.08"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2002-03", 
    "datePublishedReg": "2002-03-01", 
    "description": "Purpose. The aim of the study was to measure microcirculation parameters by dynamic contrast-enhanced MRI (d-MRI) and to evaluate the anti-angiogentic effects during treatment with thalidomide in different hematologic malignancies.Methods. In 20 healthy normal persons, 20 patients with myelodysplastic syndromes (MDS), 10 patients with multiple myeloma (MM) and 10 with myelofibrosis (MF) a fast gradient echo sequence (Turbo fast low angle shot 2D) with a pump controlled bolus infusion of gadolinium-DTPA was performed before and in 18 of these after beginning (average of 4,3 months) of a thalidomide therapy. Two pharmacokinetic parameters \u2013 the amplitude and exchange-rate-constant \u2013 were calculated and a statistical comparison of these values between healthy persons and patients as well as a correlation with the clinical course was executed.Results. Compared with the normal controls the patients showed a higher amplitude (normal persons 14.4\u00b15.2, MDS 24.8\u00b18.1, MF 35.9\u00b14.3, MM 23.4\u00b13.6) and exchange-rate-constant (normal persons 0.124\u00b10.042, MDS 0.136\u00b10.036, MF 0.144\u00b10.068, MM 0.131\u00b10.034). In the d-MRI-follow-up examinations a significant (p<0.005) reduction of the amplitude and exchange rate constant values was evident in 14 of 18 patients undergoing a thalidomide therapy. Clinically all of these patients showed a therapy responding with complete or partial diseases remission.Conclusions. In patients with hematologic malignancies significantly higher d-MRI-microcirculation parameters of the lumbar spine can be demonstrated than in normal persons. During anti-angiogenetic treatment with thalidomide a decrease of these values was observed in case of a responding to therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00117-002-0721-6", 
    "inLanguage": "de", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1018339", 
        "issn": [
          "0033-832X", 
          "1432-2102"
        ], 
        "name": "Der Radiologe", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "keywords": [
      "dynamic contrast-enhanced MRI", 
      "thalidomide therapy", 
      "myelodysplastic syndrome", 
      "multiple myeloma", 
      "hematologic malignancies", 
      "normal persons", 
      "partial disease remission", 
      "anti-angiogenetic treatment", 
      "healthy normal persons", 
      "different hematologic malignancies", 
      "contrast-enhanced MRI", 
      "disease remission", 
      "clinical course", 
      "bolus infusion", 
      "healthy persons", 
      "lumbar spine", 
      "normal controls", 
      "patients", 
      "pharmacokinetic parameters", 
      "microcirculation parameters", 
      "gadolinium-DTPA", 
      "fast gradient echo sequence", 
      "therapy", 
      "gradient echo sequence", 
      "malignancy", 
      "myelofibrosis", 
      "echo sequence", 
      "treatment", 
      "persons", 
      "statistical comparison", 
      "remission", 
      "myeloma", 
      "infusion", 
      "syndrome", 
      "MRI", 
      "spine", 
      "examination", 
      "high amplitude", 
      "aim", 
      "course", 
      "responding", 
      "decrease", 
      "control", 
      "study", 
      "cases", 
      "correlation", 
      "reduction", 
      "amplitude", 
      "effect", 
      "Beurteilung", 
      "values", 
      "pump", 
      "comparison", 
      "parameters", 
      "sequence", 
      "constants", 
      "constant value", 
      "rate constant values"
    ], 
    "name": "Dynamische kontrastverst\u00e4rkte MRT zur Beurteilung der Knochenmarksmikrozirkulation bei malignen h\u00e4matologischen Erkrankungen vor und w\u00e4hrend einer Thalidomidtherapie", 
    "pagination": "222-230", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050758582"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00117-002-0721-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11963240"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00117-002-0721-6", 
      "https://app.dimensions.ai/details/publication/pub.1050758582"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_359.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00117-002-0721-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00117-002-0721-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00117-002-0721-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00117-002-0721-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00117-002-0721-6'


 

This table displays all metadata directly associated to this object as RDF triples.

264 TRIPLES      21 PREDICATES      106 URIs      98 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00117-002-0721-6 schema:about N002b1823e0b041cf9ef6f25ffca03bb9
2 N055cc278d7154e0e84d2d7644ace4c7a
3 N0901ace5c92f4fd983b48d89799823fd
4 N1220519e3ad942b89aecf79202991b2c
5 N1720c0129bed49bf918c19fbaff1348d
6 N385862d0b6a44f7c955a810da5c11310
7 N3ad855e26e284fc18fdc6fbd3727b274
8 N4ab5e4a913bb4ad1a0d528c3f764adc7
9 N577df37217cd497f950ca7a09a8dd7dd
10 N6a12d7e1101941c28c64989cd9f4cb84
11 N7370a3df90c64957a9bea532c8b6eb5b
12 N742792e10c6044398db9a5faf0e914ff
13 N978c1ad023ef42ebaeb962999258605e
14 N99bc2ddb6d7944ea9b7dd0d23dcd8707
15 N9b9c2d6b6fec44c4b6dc4cee2534be5e
16 Nadcd0b16702b477d8d7bf66f3f00c2ac
17 Nc7ea84594631453fb8447278654cc62c
18 Nd116df63fc8b4c328ba238d2bbac4386
19 Nd205d0df51d14bb284b228c85f8cfc08
20 Nd871ab1a0c4d473583421510c16c7425
21 Nef4ea1855052497c8a4c3f42a56c73de
22 anzsrc-for:11
23 anzsrc-for:1103
24 schema:author N6bc1035594f944b4a23e6201de3aaabd
25 schema:datePublished 2002-03
26 schema:datePublishedReg 2002-03-01
27 schema:description Purpose. The aim of the study was to measure microcirculation parameters by dynamic contrast-enhanced MRI (d-MRI) and to evaluate the anti-angiogentic effects during treatment with thalidomide in different hematologic malignancies.Methods. In 20 healthy normal persons, 20 patients with myelodysplastic syndromes (MDS), 10 patients with multiple myeloma (MM) and 10 with myelofibrosis (MF) a fast gradient echo sequence (Turbo fast low angle shot 2D) with a pump controlled bolus infusion of gadolinium-DTPA was performed before and in 18 of these after beginning (average of 4,3 months) of a thalidomide therapy. Two pharmacokinetic parameters – the amplitude and exchange-rate-constant – were calculated and a statistical comparison of these values between healthy persons and patients as well as a correlation with the clinical course was executed.Results. Compared with the normal controls the patients showed a higher amplitude (normal persons 14.4±5.2, MDS 24.8±8.1, MF 35.9±4.3, MM 23.4±3.6) and exchange-rate-constant (normal persons 0.124±0.042, MDS 0.136±0.036, MF 0.144±0.068, MM 0.131±0.034). In the d-MRI-follow-up examinations a significant (p<0.005) reduction of the amplitude and exchange rate constant values was evident in 14 of 18 patients undergoing a thalidomide therapy. Clinically all of these patients showed a therapy responding with complete or partial diseases remission.Conclusions. In patients with hematologic malignancies significantly higher d-MRI-microcirculation parameters of the lumbar spine can be demonstrated than in normal persons. During anti-angiogenetic treatment with thalidomide a decrease of these values was observed in case of a responding to therapy.
28 schema:genre article
29 schema:inLanguage de
30 schema:isAccessibleForFree false
31 schema:isPartOf N72dc06c7003446ec917f6f4e21b22dae
32 Nbadf0a251edc4b1aa51e77ef9f484991
33 sg:journal.1018339
34 schema:keywords Beurteilung
35 MRI
36 aim
37 amplitude
38 anti-angiogenetic treatment
39 bolus infusion
40 cases
41 clinical course
42 comparison
43 constant value
44 constants
45 contrast-enhanced MRI
46 control
47 correlation
48 course
49 decrease
50 different hematologic malignancies
51 disease remission
52 dynamic contrast-enhanced MRI
53 echo sequence
54 effect
55 examination
56 fast gradient echo sequence
57 gadolinium-DTPA
58 gradient echo sequence
59 healthy normal persons
60 healthy persons
61 hematologic malignancies
62 high amplitude
63 infusion
64 lumbar spine
65 malignancy
66 microcirculation parameters
67 multiple myeloma
68 myelodysplastic syndrome
69 myelofibrosis
70 myeloma
71 normal controls
72 normal persons
73 parameters
74 partial disease remission
75 patients
76 persons
77 pharmacokinetic parameters
78 pump
79 rate constant values
80 reduction
81 remission
82 responding
83 sequence
84 spine
85 statistical comparison
86 study
87 syndrome
88 thalidomide therapy
89 therapy
90 treatment
91 values
92 schema:name Dynamische kontrastverstärkte MRT zur Beurteilung der Knochenmarksmikrozirkulation bei malignen hämatologischen Erkrankungen vor und während einer Thalidomidtherapie
93 schema:pagination 222-230
94 schema:productId N524e2d1fce274cc2b84fa59938696b64
95 N93b8470f82ce4f42b14e74c25b898292
96 Nc28630a6bd0240a4b210f662bb51dc36
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050758582
98 https://doi.org/10.1007/s00117-002-0721-6
99 schema:sdDatePublished 2022-05-20T07:22
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher N2de79fade89144b69e5dea6d0059978f
102 schema:url https://doi.org/10.1007/s00117-002-0721-6
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N002b1823e0b041cf9ef6f25ffca03bb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Bone Marrow
108 rdf:type schema:DefinedTerm
109 N055cc278d7154e0e84d2d7644ace4c7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Microcirculation
111 rdf:type schema:DefinedTerm
112 N0901ace5c92f4fd983b48d89799823fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Adult
114 rdf:type schema:DefinedTerm
115 N0d9f3c97a5dd42bb802671980d11d18b rdf:first sg:person.01077215375.32
116 rdf:rest N52c8ebe095714e3196b6382d29846661
117 N1220519e3ad942b89aecf79202991b2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Male
119 rdf:type schema:DefinedTerm
120 N1720c0129bed49bf918c19fbaff1348d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Female
122 rdf:type schema:DefinedTerm
123 N2de79fade89144b69e5dea6d0059978f schema:name Springer Nature - SN SciGraph project
124 rdf:type schema:Organization
125 N385862d0b6a44f7c955a810da5c11310 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Angiogenesis Inhibitors
127 rdf:type schema:DefinedTerm
128 N39a9531d24384a18a348a5e8e386c482 rdf:first sg:person.01273447501.34
129 rdf:rest N74c06f0676ae4997ba62925ccc65b6cd
130 N3ad855e26e284fc18fdc6fbd3727b274 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Multiple Myeloma
132 rdf:type schema:DefinedTerm
133 N42c7549c22e94ec080833c4889e404d0 rdf:first sg:person.01001653715.11
134 rdf:rest Nfe64de63491c4aa68f2599c415e7bf8d
135 N4ab5e4a913bb4ad1a0d528c3f764adc7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Humans
137 rdf:type schema:DefinedTerm
138 N524e2d1fce274cc2b84fa59938696b64 schema:name pubmed_id
139 schema:value 11963240
140 rdf:type schema:PropertyValue
141 N52c8ebe095714e3196b6382d29846661 rdf:first sg:person.010643554674.37
142 rdf:rest Nd45a4129a4a746529cf69e65427af55a
143 N577df37217cd497f950ca7a09a8dd7dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Treatment Outcome
145 rdf:type schema:DefinedTerm
146 N6a12d7e1101941c28c64989cd9f4cb84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Image Enhancement
148 rdf:type schema:DefinedTerm
149 N6bc1035594f944b4a23e6201de3aaabd rdf:first sg:person.0627026525.04
150 rdf:rest N42c7549c22e94ec080833c4889e404d0
151 N72dc06c7003446ec917f6f4e21b22dae schema:issueNumber 3
152 rdf:type schema:PublicationIssue
153 N7370a3df90c64957a9bea532c8b6eb5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Gadolinium DTPA
155 rdf:type schema:DefinedTerm
156 N742792e10c6044398db9a5faf0e914ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Myelodysplastic Syndromes
158 rdf:type schema:DefinedTerm
159 N74c06f0676ae4997ba62925ccc65b6cd rdf:first sg:person.01127414674.14
160 rdf:rest N9241c5df3f7d4dcd9fc09e6700354d12
161 N9241c5df3f7d4dcd9fc09e6700354d12 rdf:first sg:person.0637037231.08
162 rdf:rest rdf:nil
163 N93b8470f82ce4f42b14e74c25b898292 schema:name doi
164 schema:value 10.1007/s00117-002-0721-6
165 rdf:type schema:PropertyValue
166 N978c1ad023ef42ebaeb962999258605e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Primary Myelofibrosis
168 rdf:type schema:DefinedTerm
169 N99bc2ddb6d7944ea9b7dd0d23dcd8707 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Contrast Media
171 rdf:type schema:DefinedTerm
172 N9b9c2d6b6fec44c4b6dc4cee2534be5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Image Processing, Computer-Assisted
174 rdf:type schema:DefinedTerm
175 Nadcd0b16702b477d8d7bf66f3f00c2ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Magnetic Resonance Imaging
177 rdf:type schema:DefinedTerm
178 Nbadf0a251edc4b1aa51e77ef9f484991 schema:volumeNumber 42
179 rdf:type schema:PublicationVolume
180 Nc28630a6bd0240a4b210f662bb51dc36 schema:name dimensions_id
181 schema:value pub.1050758582
182 rdf:type schema:PropertyValue
183 Nc7ea84594631453fb8447278654cc62c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Lumbar Vertebrae
185 rdf:type schema:DefinedTerm
186 Nd116df63fc8b4c328ba238d2bbac4386 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Neovascularization, Pathologic
188 rdf:type schema:DefinedTerm
189 Nd205d0df51d14bb284b228c85f8cfc08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Aged
191 rdf:type schema:DefinedTerm
192 Nd45a4129a4a746529cf69e65427af55a rdf:first sg:person.01362464041.20
193 rdf:rest N39a9531d24384a18a348a5e8e386c482
194 Nd871ab1a0c4d473583421510c16c7425 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Middle Aged
196 rdf:type schema:DefinedTerm
197 Nef4ea1855052497c8a4c3f42a56c73de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Thalidomide
199 rdf:type schema:DefinedTerm
200 Nfe64de63491c4aa68f2599c415e7bf8d rdf:first sg:person.0675141725.09
201 rdf:rest N0d9f3c97a5dd42bb802671980d11d18b
202 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
203 schema:name Medical and Health Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
206 schema:name Clinical Sciences
207 rdf:type schema:DefinedTerm
208 sg:journal.1018339 schema:issn 0033-832X
209 1432-2102
210 schema:name Der Radiologe
211 schema:publisher Springer Nature
212 rdf:type schema:Periodical
213 sg:person.01001653715.11 schema:affiliation grid-institutes:grid.411327.2
214 schema:familyName Strupp
215 schema:givenName C.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001653715.11
217 rdf:type schema:Person
218 sg:person.010643554674.37 schema:affiliation grid-institutes:grid.411327.2
219 schema:familyName Willers
220 schema:givenName R.
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010643554674.37
222 rdf:type schema:Person
223 sg:person.01077215375.32 schema:affiliation grid-institutes:grid.411327.2
224 schema:familyName Engelbrecht
225 schema:givenName V.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077215375.32
227 rdf:type schema:Person
228 sg:person.01127414674.14 schema:affiliation grid-institutes:grid.411327.2
229 schema:familyName Haas
230 schema:givenName R.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14
232 rdf:type schema:Person
233 sg:person.01273447501.34 schema:affiliation grid-institutes:grid.411327.2
234 schema:familyName Gattermann
235 schema:givenName N.
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34
237 rdf:type schema:Person
238 sg:person.01362464041.20 schema:affiliation grid-institutes:grid.411327.2
239 schema:familyName Germing
240 schema:givenName U.
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20
242 rdf:type schema:Person
243 sg:person.0627026525.04 schema:affiliation grid-institutes:grid.411327.2
244 schema:familyName Scherer
245 schema:givenName A.
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627026525.04
247 rdf:type schema:Person
248 sg:person.0637037231.08 schema:affiliation grid-institutes:grid.411327.2
249 schema:familyName Mödder
250 schema:givenName U.
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637037231.08
252 rdf:type schema:Person
253 sg:person.0675141725.09 schema:affiliation grid-institutes:grid.411327.2
254 schema:familyName Wittsack
255 schema:givenName H.-J.
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675141725.09
257 rdf:type schema:Person
258 grid-institutes:grid.411327.2 schema:alternateName Institut für Diagnostische Radiologie, Heinrich-Heine Universität Düsseldorf, Germany
259 Klinik für Hämatologie, Onkologie und klinische Immunologie, Heinrich-Heine Universität Düsseldorf, Germany
260 Universitätsrechenzentrum, Heinrich-Heine Universität Düsseldorf, Germany
261 schema:name Institut für Diagnostische Radiologie, Heinrich-Heine Universität Düsseldorf, Germany
262 Klinik für Hämatologie, Onkologie und klinische Immunologie, Heinrich-Heine Universität Düsseldorf, Germany
263 Universitätsrechenzentrum, Heinrich-Heine Universität Düsseldorf, Germany
264 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...